Volk E E, Prayson R A
Department of Anatomic Pathology, Cleveland Clinic Foundation, OH 44195, USA.
Hum Pathol. 1997 Feb;28(2):227-32. doi: 10.1016/s0046-8177(97)90111-8.
Hamartomas are a poorly defined group of lesions and a rare cause of chronic epilepsy. We studied 13 patients, nine males and four females, whose cause of seizures was attributed to a hamartoma. The patients ranged in age from 6 to 33 years (mean, 21 years). Seizure duration before surgery ranged from 1.5 to 22 years (mean, 10 years). Seven hamartomas were located on the right side and six on the left. Six were located in the frontal lobe, five in the temporal lobe, and two in the occipital lobe. Twelve patients underwent gross total resection of the lesion and one a partial resection. All consisted of a circumscribed, disorganized collection of glial cells, primarily astrocytes. Rarely a neuronal component was admixed. One lesion contained an increased number of small blood vessels. Eight (62%) hamartomas contained eosinophilic granular bodies, and focal microcalcification was observed in three lesions (23%). Adjacent cortical architectural abnormalities (cortical dysplasia) were identified in eight (62%) resection specimens. Necrosis, mitoses, and prominent cytological atypia were absent in all lesions. Differential diagnostic considerations include low grade astrocytoma, ganglioglioma, dysembryoplastic neuroepithelial tumor, and cortical dysplasia. Postoperatively, 10 patients (77%) had complete resolution or greater than 90% reduction of seizure frequency. Two patients (16%) developed recurrent seizures 8 and 13 months postoperatively. One patient who underwent a partial resection showed no decrease in seizure frequency. No lesion recurrence on imaging studies has been observed in the 12 patients who underwent gross total resection of their hamartoma during 1 to 51 months (mean, 14 months) follow-up. We conclude that hamartomas seen in the setting of chronic epilepsy are generally low-grade lesions that respond well to gross total resection. Circumscription and lack of significant cytological atypia help distinguish these lesions from other neoplastic causes of epilepsy. Hamartomas that arise in the setting of chronic epilepsy appear to be associated with increased incidence of cortical architectural abnormalities (cortical dysplasia) and represent maldevelopmental lesions.
错构瘤是一组定义不明确的病变,是慢性癫痫的罕见病因。我们研究了13例患者,其中男性9例,女性4例,其癫痫发作原因归因于错构瘤。患者年龄在6至33岁之间(平均21岁)。手术前癫痫发作持续时间为1.5至22年(平均10年)。7个错构瘤位于右侧,6个位于左侧。6个位于额叶,5个位于颞叶,2个位于枕叶。12例患者接受了病变的全切除,1例接受了部分切除。所有错构瘤均由界限清楚、排列紊乱的胶质细胞组成,主要为星形胶质细胞。很少混有神经元成分。1个病变含有数量增多的小血管。8个(62%)错构瘤含有嗜酸性颗粒体,3个病变(23%)观察到局灶性微钙化。8个(62%)切除标本中发现相邻皮质结构异常(皮质发育异常)。所有病变均无坏死、核分裂及明显的细胞异型性。鉴别诊断需考虑低级别星形细胞瘤、神经节细胞胶质瘤、胚胎发育不良性神经上皮肿瘤和皮质发育异常。术后,10例患者(77%)癫痫发作完全缓解或发作频率降低超过90%。2例患者(16%)在术后8个月和13个月出现癫痫复发。1例接受部分切除的患者癫痫发作频率未降低。在接受错构瘤全切除的12例患者中,随访1至51个月(平均14个月),影像学检查未观察到病变复发。我们得出结论,慢性癫痫背景下的错构瘤通常是低级别病变,对全切除反应良好。界限清楚及无明显细胞异型性有助于将这些病变与癫痫的其他肿瘤性病因相鉴别。慢性癫痫背景下出现的错构瘤似乎与皮质结构异常(皮质发育异常)的发生率增加有关,代表发育异常性病变。